Today: 20 May 2026
DroneShield Stock Skyrockets 40%: What’s Behind the Surge and What’s Next?
17 November 2025
2 mins read

DroneShield (ASX:DRO) share price today, 17 Nov 2025: rebounds 11.6% to $2.60 as broker turns bearish and governance debate flares

Summary: DroneShield shares bounced on Monday after last week’s rout, closing up 11.6% at A$2.60 on heavy volume. The move unfolded alongside fresh coverage of governance concerns and a notable rebuke from the company’s own house broker later in the day.


DroneShield share price today (ASX: DRO)

  • Close:A$2.60 (+11.59%)
  • Trading range:A$2.32 – A$2.60
  • Open:A$2.36
  • Volume:~31.7 million shares

(All figures are for Monday, 17 Nov 2025.)

For international holders, DroneShield’s US OTC listing DRSHF most recently traded around US$1.76 in Monday data.


What moved the stock

A sharp relief rally after last week’s plunge
The bounce follows a brutal sell‑off on 13 Nov after large director selldowns, which saw the share price sink to A$2.25 intraday and wipe hundreds of millions from the market cap.

Morning: “on the rise” coverage
Before lunch, ABC’s The Business highlighted DroneShield among stocks rebounding, noting the company’s rally despite broader market jitters. ABC

Mid‑day to evening: governance and broker backlash stay in focus

  • Governance debate: ABC ran a segment featuring experts calling for a cooling‑off window to prevent directors selling immediately after market‑moving ASX announcements, a topic aired in direct response to DroneShield’s recent events.
  • House broker turns cold: After the close, the Australian Financial Review reported that DroneShield’s house broker has turned on the stock, labelling it “dead money” following the CEO’s major sale—an unusually harsh stance from a company-aligned broker. AFR
  • Big holders feeling the blast radius: AFR’s Rear Window column also explored how high‑profile investors have been caught in the fallout from the share slump.
  • Fund managers’ frustration: Independent coverage captured the market’s mood, with fund managers describing the selldown as a breaking point for confidence.

The backdrop: why sentiment snapped last week

  • Large director selldowns disclosed
    ASX filings show CEO Oleg Vornik sold 14.8 million shares at about A$3.34 (≈ A$49.5m). Chairman Peter James sold ~3.69 million shares across two trades for a combined ≈A$12.35m, and director Jethro Marks sold 1.46 million shares for ≈A$4.89m—all on 12 Nov.
    Independent reporting the next day described the resulting 31% price plunge to around A$2.25, underscoring how the selldowns jarred investors.
  • Withdrawn ASX announcement (10 Nov)
    DroneShield withdrew an earlier notice touting A$7.6m in US handheld‑systems orders, clarifying the contracts were reissued, not new, and attributing the error to administration. The Board said it would put steps in place to prevent a repeat.

Together, the mis‑flagged contracts and insider sales created a credibility overhang that continued to shape commentary today, even as the share price recovered.


How today’s rebound fits the trend

  • Price action: Monday’s close at A$2.60 leaves the stock still well below last week’s pre‑selloff levels above A$3.20–A$3.30, but shows buyers stepping back in after forced and panic selling.
  • Liquidity: Turnover of ~31.7m shares indicates active two‑way trade as investors re‑price near‑term risks and potential.

What to watch next

  1. Broker research and target changes
    The house broker’s “dead money” call is likely to echo across the market and may influence short‑term flows as institutions reassess positions and analysts revisit assumptions. AFR
  2. Governance signals
    With governance commentators urging rule tweaks on director trading windows after announcements, watch for any ASX guidance or company‑level updates on internal trading policies.
  3. Company disclosures and contract cadence
    After the withdrawal of the 10 Nov contract announcement, investors will look for clean execution updates and fresh, clearly framed orders.
  4. Event calendar
    Based on published calendars, DroneShield’s next scheduled reporting window is February 2026 (prelim/annual), barring any ad‑hoc updates.

Key takeaways for today (17 Nov 2025)

  • DRO closed at A$2.60, +11.6%, with A$2.32–A$2.60 range and ~31.7m volume.
  • Narrative remains fragile: governance critiques and the house‑broker’s “dead money” tag kept pressure on sentiment even as the price bounced. ABC+1
  • Last week’s triggers: major insider sales and a withdrawn contract announcement continue to color risk perceptions.

This article is provided for news and information purposes only and is not financial advice. Always consider your objectives and risk tolerance and consult a licensed adviser before making investment decisions.

Stock Market Today

  • Roivant Sciences Q4 Loss Beats Estimates; Revenue Misses
    May 20, 2026, 9:59 AM EDT. Roivant Sciences Ltd. reported a fourth-quarter loss of $0.23 per share, better than the Zacks estimate of a $0.25 loss, marking an 8% positive earnings surprise. Revenue missed expectations, coming in at $28.93 million, down 11% from estimates but up from $27.38 million a year ago. Despite three out of four quarters beating EPS estimates recently, the company's shares have declined 4.5% year-to-date, underperforming the S&P 500's 10.4% rise. Earnings outlook remains cautious with a Zacks Rank #4 (Sell), suggesting expected near-term underperformance. Current consensus projects a loss of $0.21 per share next quarter on $56.64 million revenue and a fiscal year loss of $1.07 on $172.45 million. Industry outlook in medical-biomedical genetics also weighs on investor sentiment.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong
Previous Story

Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong

Emirates to Offer Free Starlink Wi‑Fi on All Boeing 777 and A380 Flights by Mid‑2027
Next Story

Emirates to Offer Free Starlink Wi‑Fi on All Boeing 777 and A380 Flights by Mid‑2027

Go toTop